Rare Disease Day is internationally recognized every year on February 28 to raise awareness, generate change, and improve access to treatment for the 300 million people worldwide living with a rare disease, their families and carers. This year, we spotlight a SPARK team that is using a growing therapeutic modality, antisense oligonucleotides, to develop a therapy for a single pediatric patient with a rare genetic mutation. Their hope is that by carefully and methodically outlining the process to develop this therapy, they will remove barriers to developing this type of treatment for other rare disease patients.
Learn MoreFounder and Director of Stanford University’s SPARK program Daria Mochly-Rosen shares how she has liberated potential drug discoveries from academic research to industry, and discusses the countless, surprising lessons she has learned along the way.
For manuscript submissions, use this sentence in the acknowledgement:
“Mentored and financially supported by Stanford’s SPARK Translational Research Program”
Lessons learned from SPARK influence team's work
California Life Sciences' Pantheon Awards celebrate excellence in California’s life sciences sector
Oppenheimer's Highlights from 6th Annual Emerging Science Summit
The SPARK manual was published by co-founders Daria Mochly-Rosen and Kevin Grimes to help other academic institutions develop their own SPARK Programs.
Learn MoreSPARK is thankful for the continued support of the Maternal and Child Health Research Institute at Stanford. Through their funding, SPARK has been able fund numerous projects in the field of Child and Maternal Health with 11 projects reaching clinic or commercial sectors.
Learn MoreA number of academic institutions have successfully developed their own SPARK programs resulting in a global community of translational scientists who accelerate academic discoveries to patients around the world. Learn more about the work of SPARK Global.
Learn MoreJun21